Prestige Consumer Healthcare
PBH
#3909
Rank
NZ$5.51 B
Marketcap
NZ$112.06
Share price
-0.49%
Change (1 day)
-17.14%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): NZ$7.02

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is NZ$7.06. In 2024 the company made an earnings per share (EPS) of NZ$7.47 an increase over its 2023 EPS that were of NZ-$2.80.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$7.02-6.06%
2024NZ$7.47-367.08%
2023NZ-$2.80-138.33%
2022NZ$7.3011.7%
2021NZ$6.5413.6%
2020NZ$5.75-651.67%
2019NZ-$1.04-148.78%
2018NZ$2.14-83.29%
2017NZ$12.79437.23%
2016NZ$2.38-34.13%
2015NZ$3.6252.94%
2014NZ$2.36-8.11%
2013NZ$2.57
2011NZ$1.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
GlaxoSmithKline
GSK
NZ$6.25-11.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
NZ$2.99-57.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Rite Aid
RAD
NZ-$51.49-829.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$18.15 157.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
NZ$2.12-69.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
NZ$12.79 81.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Procter & Gamble
PG
NZ$12.22 73.15%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
NZ$0.70-90.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
NZ$11.14 57.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$14.00 98.45%๐Ÿ‡บ๐Ÿ‡ธ USA